SMTL ID : 7x3l.2 (1 other biounit)

Crystal structure of Aldo-keto reductase 1C3 complexed with compound S07044

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.86 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 29 residues within 4Å: Chain A: G.28, T.29, Y.30, D.56, Y.61, K.90, H.123, S.172, N.173, Q.196, Y.222, S.223, A.224, L.225, G.226, S.227, Q.228, L.242, A.259, L.274, A.275, K.276, S.277, Y.278, N.279, R.282, Q.285, N.286 Ligands: 8FO.2 30 PLIP interactions: 30 interactions with chain A Hydrogen bonds: A:T.29, A:Y.30, A:D.56, A:D.56, A:Y.61, A:S.172, A:N.173, A:Q.196, A:S.223, A:L.225, A:S.227, A:Q.228, A:Q.228, A:L.274, A:K.276, A:S.277, A:Y.278, A:Q.285, A:N.286 Water bridges: A:S.223, A:A.224, A:A.224, A:S.227, A:T.257, A:R.282, A:Q.285 Salt bridges: A:K.276, A:R.282 pi-Stacking: A:Y.222 pi-Cation interactions: A:R.282

1 x 8FO: (2~{R})-2-[4-(3-fluoranyl-4-methyl-phenyl)-3-(trifluoromethyl)phenyl]butanoic acid(Non-covalent)

8FO.2: 15 residues within 4Å: Chain A: Y.30, Y.61, W.92, H.123, S.124, M.126, N.173, Y.222, W.233, F.312, F.317, Y.323, P.324, Y.325 Ligands: NAP.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.30, A:W.233, A:F.312, A:F.317, A:F.317, A:Y.323, A:Y.325 Salt bridges: A:K.90, A:H.123 pi-Stacking: A:F.312 Halogen bonds: A:H.123, A:N.173

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

He, S. et al., Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment. J.Med.Chem. (2023)

Release Date

2023-03-08

Peptides

Aldo-keto reductase family 1 member C3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Aldo-keto reductase family 1 member C3

Related Entries With Identical Sequence